Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 384

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

Open access
Bogunovic, Dusan, O'Neill, David W., Belitskaya-Levy, Ilana, Vacic, Vladimir, Yu, Yi-Lo, Adams, Sylvia, Darvishian, Farbod, Berman, Russell, Shapiro, Richard, Pavlick, Anna C., Lonardi, Stefano, Zavadil, Jiri, Osman, Iman, Bhardwaj, Nina · 2009 · Proceedings of the National Academy of Sciences

Abstract

Although remission rates for metastatic melanoma are generally very poor, some patients can survive for prolonged periods following metastasis. We used gene expression profiling, mitotic index (MI), and quantification of tumor infiltrating leukocytes (TILs) and CD3+ cells in metastatic lesions to search for a molecular basis for this observation and to develop improved methods for predicting patient survival. We identified a group of 266 genes associated with postrecurrence survival. Genes positively associated with survival were predominantly immune response related (e.g.,ICOS,CD3d,ZAP70,TRAT1,TARP,GZMK,LCK,CD2,CXCL13,CCL19,CCR7,VCAM1) while genes negatively associated with survival were cell proliferation related (e.g.,PDE4D,CDK2,GREF1,NUSAP1,SPC24). Furthermore, any of the 4 parameters (prevalidated gene expression signature, TILs, CD3, and in particular MI) improved the ability of Tumor, Node, Metastasis (TNM) staging to predict postrecurrence survival; MI was the most significant contributor (HR = 2.13,P= 0.0008). An immune response gene expression signature and presence of TILs and CD3+ cells signify immune surveillance as a mechanism for prolonged survival in these patients and indicate improved patient subcategorization beyond current TNM staging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0905139106

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 384

Metadata

Authors
Bogunovic, D., O'Neill, D. W., Belitskaya-Levy, I., Vacic, V., Yu, Y.-L., Adams, S., Darvishian, F., Berman, R., Shapiro, R., Pavlick, A. C., Lonardi, S., Zavadil, J., Osman, I., & Bhardwaj, N.
Venue
Proceedings of the National Academy of Sciences
Published
2009-12
Volume
106
Issue
48
Pages
20429-20434
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1977852460
Cited by
384
References
26
FWCI
9.70
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. https://app.cochat.ai/papers/10.1073/pnas.0905139106
The paper
Bogunovic, D., O'Neill, D. W., Belitskaya-Levy, I., Vacic, V., Yu, Y.-L., Adams, S., Darvishian, F., Berman, R., Shapiro, R., Pavlick, A. C., Lonardi, S., Zavadil, J., Osman, I., & Bhardwaj, N. (2009). Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0905139106

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.